Possible mechanism of action of deprenyl in parkinsonism
- 21 July 1990
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 336 (8708) , 183
- https://doi.org/10.1016/0140-6736(90)91709-j
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- 2‐Phenylethylamine: A Modulator of Catecholamine Transmission in the Mammalian Central Nervous System?Journal of Neurochemistry, 1990
- Parkinson's diseaseThe Lancet, 1990
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's DiseaseScience, 1989
- N, N-dipropargyl-2-phenylethylamine, a potential prodrug of 2-phenylethylamine: Neurochemical and neuropharmacological studies in ratBrain Research Bulletin, 1987
- Monoamine Oxidase Activity and Monoamine Metabolism in Brains of Parkinsonian Patients Treated with l‐DeprenylJournal of Neurochemistry, 1986
- Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons.Proceedings of the National Academy of Sciences, 1982
- IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASEThe Lancet, 1977